People With Acne Have Far Less Diverse Gut Bacteria, Study Finds

If you've cycled through topical retinoids, antibiotics, and spot treatments and your acne still won't fully clear, the missing piece might not be on your skin at all. A new pilot study is among the first to directly compare gut and skin bacteria in the same acne patients, and the imbalance it found was overwhelmingly in the gut, not on the face. People with moderate-to-severe acne carried a gut microbiome that looked markedly less diverse than that of people with clear skin, a gap large enough to be statistically unmistakable. It's early evidence from a small study, but it adds real weight to the idea that acne may be, at least in part, a whole-body issue rather than a purely surface-level one.

Key Takeaways

• People with moderate-to-severe acne had gut bacterial diversity roughly three times lower than clear-skinned controls (62.71 vs. 190.87 distinct bacterial types).
• The gut disruption was far more pronounced than any change on the skin itself, suggesting the gut may be the more informative signal to watch.
• The study only shows a correlation. It cannot tell us whether low gut diversity contributes to acne, results from it, or reflects some third factor like diet.
• With just 31 participants and no control for diet, BMI, or medication use, this is a hypothesis-generating finding, not a green light for gut-focused acne treatments.

Gut Bacterial Diversity Drops Sharply in Acne Patients

Adults with moderate-to-severe acne carry a far less varied population of gut bacteria than people with clear skin, according to a study published in Frontiers in Cellular and Infection Microbiology in 2026 by A. Lesiak, A. Krawczyk, and colleagues (full study). The researchers measured gut diversity using the Shannon index (a standard ecology metric that scores a bacterial community by both how many different species are present and how evenly balanced they are), and the acne group's score of 2.46 came in far below the control group's 3.93, a difference strong enough that it's very unlikely to be due to chance (p<0.001). In practical terms, acne patients carried around 62.71 distinct types of gut bacteria on average, compared to 190.87 in healthy controls, roughly a threefold gap. The acne group's gut communities also leaned toward more Bacillota and less Bacteroidota (two of the major bacterial groups, or phyla, that make up most of the human gut), a shift that shows up in several other conditions linked to gut imbalance.

Why This Matters for People With Moderate-to-Severe Acne

If you have moderate-to-severe acne that hasn't responded well to standard topical treatment, this study is a signal that what's happening in your gut may deserve as much attention as what's happening on your face. The researchers specifically studied adults with clinically significant, ongoing acne, not occasional teenage breakouts, which is the population most likely to have already tried multiple skin-directed treatments without full success. The reason this matters: if the gut-skin connection holds up under further research, it reframes stubborn acne as potentially a systemic issue rather than something that can always be resolved by treating the skin in isolation. That's a meaningful shift for anyone who has felt like they've done everything for their skin and still isn't seeing results.

How Researchers Compared Gut and Skin Samples

The study's credibility comes from its paired design: the researchers collected both a stool sample and a facial skin swab from every one of the 31 participants, 17 with moderate-to-severe acne and 14 healthy controls, and sequenced the bacterial DNA in each sample. That paired approach let the team compare gut and skin bacteria within the same person rather than relying on separate, unmatched groups, which is what makes the gut-versus-skin contrast in this study meaningful despite the small sample. Notably, skin microbiome diversity was also modestly lower in the acne group (p=0.006), but unlike the gut, the overall mix of bacterial species on acne patients' skin was not significantly different from controls'. That asymmetry, a clear gut signal alongside a much weaker skin signal, is the study's most distinctive finding.

What This Means for Your Next Doctor Visit

For most readers, the practical takeaway is a conversation starter, not a treatment plan. If you have persistent acne alongside gut symptoms such as bloating, irregular digestion, or a diet you already suspect is out of balance, it's reasonable to mention that to a dermatologist or primary care doctor and ask whether a broader workup makes sense. What this study does not support is buying a probiotic or supplement marketed as an acne fix. No probiotic or gut intervention has been proven in this study, or in rigorous trials generally, to treat or improve acne, and self-treating based on a single pilot study risks wasted money at best. This research is most relevant to adults with moderate-to-severe, treatment-resistant acne. It says nothing about occasional breakouts, hormonal acne in isolation, or other skin conditions.

The Correlation-Causation Question This Study Can't Answer

The central limitation is one the researchers themselves acknowledge: this study shows association, not cause. It cannot determine whether low gut bacterial diversity contributes to acne, whether acne (and behaviors that come with it, like diet changes or medication use) disrupts gut bacteria, or whether some unmeasured third factor drives both. With only 31 total participants, and without controlling for diet, body mass index, or medication differences between the two groups, any of those factors could be quietly shaping the results. The study also only sequenced bacteria, not fungi or viruses, and its sequencing method can't identify bacteria down to the strain level, so some biologically important detail is likely missing from the picture entirely.

What Comes Next in Gut-Skin Axis Research

The logical next step is a larger, controlled study that accounts for diet, BMI, and medication use from the outset, and ideally tracks people over time rather than comparing two groups at a single moment. A longitudinal design would help establish sequence, whether gut diversity loss precedes acne onset or follows it, which is the key question this pilot study cannot resolve. The researchers did not specify a timeline for follow-up work, but studies like this one typically function as a first step that justifies funding for a bigger, more tightly controlled trial. Until that happens, this remains a genuinely interesting lead rather than a settled piece of the acne puzzle.

Common Questions

Does this study prove gut health causes acne?

No. The study found a strong statistical association between low gut bacterial diversity and moderate-to-severe acne, but it's a snapshot comparison, not a study that tracked cause and effect over time. Researchers explicitly note it cannot establish whether gut dysbiosis causes acne, results from it, or is linked to both through a separate factor.

Should I take a probiotic for my acne based on this?

Not based on this study. No probiotic or supplement was tested here, and no gut-focused treatment has been proven to improve acne in rigorous clinical trials to date.

How big was the study, and does that matter?

It included just 31 people total, 17 with moderate-to-severe acne and 14 healthy controls. That's large enough to produce a statistically strong signal for gut diversity, but far too small to rule out confounding factors like diet or medication use.

What's the difference between the gut and skin findings?

Gut bacterial diversity was sharply lower in acne patients and the mix of bacterial types was different from controls. Skin diversity was only modestly lower, and the overall types of bacteria on the skin weren't significantly different, making the gut the more striking finding in this study.

References

1. Agata Lesiak, Agnieszka Krawczyk, Justyna Piasta, et al. (2026). Gut and skin dysbiosis in acne vulgaris: a comparative microbiome analysis. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1904271